Qiagen

$54.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.60 (+1.12%) Today

+$0.47 (+0.87%) As of 1:55 PM UTC after-hours

Why Robinhood?

You can buy or sell Qiagen and other stocks, options, and ETFs commission-free!

About QGEN

Qiagen NV, also called Qiagen, is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands. The listed name for QGEN is Qiagen NV.

CEO

Thierry Bernard

Employees

5,096

Headquarters

Venlo, Limburg

Founded

1996

Market Cap

12.45B

Price-Earnings Ratio

66.18

Dividend Yield

—

Average Volume

743.01K

High Today

$54.69

Low Today

$53.86

Open Price

$54.06

Volume

536.63K

52 Week High

$55.27

52 Week Low

$32.97

Collections

Analyst Ratings

47%

of 19 ratings

Buy

47%

Hold

47%

Sell

QGEN Earnings

$0.00

$0.19

$0.39

$0.58

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 4